William Blair Investment Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-819,996
Closed -$21.4M 421
2022
Q1
$21.4M Buy
819,996
+17,726
+2% +$503K 0.06% 277
2021
Q4
$31.8M Buy
802,270
+8,571
+1% +$391K 0.09% 249
2021
Q3
$39.7M Buy
793,699
+8,395
+1% +$458K 0.11% 216
2021
Q2
$43.6M Sell
785,304
-31,714
-4% -$1.69M 0.14% 156
2021
Q1
$38.2M Buy
817,018
+62,581
+8% +$3.03M 0.12% 163
2020
Q4
$32.8M Buy
754,437
+74,195
+11% +$2.74M 0.11% 163
2020
Q3
$24.9M Buy
680,242
+23,215
+4% +$788K 0.1% 172
2020
Q2
$19.2M Buy
657,027
+163,994
+33% +$4.53M 0.08% 191
2020
Q1
$12.9M Buy
+493,033
New +$15.1M 0.06% 212

Other funds holding HCAT

William Blair Investment Management's HCAT Position: Q2 2022 in Review

William Blair Investment Management sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 819,996 shares — an estimated $21.4M sold.

William Blair Investment Management first reported a position in HCAT in Q1 2020 and held it in 9 quarters. The position peaked at $43.6M in Q2 2021. 179 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

  • William Blair Investment Management reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
  • William Blair Investment Management sold 819,996 Health Catalyst shares in Q2 2022, an estimated $21.4M.
  • William Blair Investment Management first reported a position in Health Catalyst in Q1 2020 and held it in 9 quarters.
  • William Blair Investment Management's Health Catalyst position peaked at $43.6M in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on William Blair Investment Management's 13F filing for Q2 2022, filed 10 Aug 2022.